Navigation Links
Alzheimer's Drug Discovery Foundation Presents its 8th Annual Drug Discovery for Neurodegeneration Conference in February 2014
Date:12/5/2013

NEW YORK, Dec. 5, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) presents its annual winter conference, the 8th Annual Drug Discover for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs, taking place on February 2-4, 2014 at the Miami Beach Resort in Miami, Florida.

(Logo: http://photos.prnewswire.com/prnh/20130909/DC75486LOGO)

Designed as a comprehensive course on the drug discovery process, from target validation through to clinical development, the annual Drug Discovery for Neurodegeneration conference provides participants with the fundamental knowledge and resources to translate their research into new drugs to treat and prevent Alzheimer's disease and related neurodegenerative diseases. 
 
Attendees from academia and industry will also learn from specific case studies examples and will have an opportunity to engage in interactive discussions on securing partnerships. The program will include a focus on Alzheimer's disease, Parkinson's disease and Multiple Sclerosis.

For more information about this conference, sponsorship opportunities, or to register please visit our conference website or contact Sara Classen, Manager of Scientific Conferences & Meetings at sclassen@alzdiscovery.org or 212-901-8009.

About the Alzheimer's Drug Discovery Foundation (www.AlzDiscovery.org)

The mission of the Alzheimer's Drug Discovery Foundation (ADDF) is to accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. The ADDF has granted more than $60 million to fund almost 400 Alzheimer's drug discovery programs in academic centers and biotechnology companies in 18 countries.


'/>"/>
SOURCE Alzheimer's Drug Discovery Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
2. Alzheimers Drug Discovery Foundation Expands its ADDF ACCESS Program to Improve Quality and Efficiency of Drug Research for Neurodegenerative Diseases
3. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
4. Berg Receives Frost & Sullivan 2013 Drug Discovery Technology Innovation Award
5. Metabolic Solutions Development Company presents Phase 2a clinical trial results at the 14th International Conference on Alzheimers Drug Discovery
6. KemPharm Continues to Expand its Pain Therapy Pipeline with Discovery of KP606, a Novel Prodrug of Oxycodone
7. Novel Use of Pressure BioSciences Patented PCT Platform Offers New Insights into Protein Structure and Function, New Tool for Biomarker Discovery and Rational Drug Design
8. Alzheimers Drug Discovery Foundation Supports Madera Biosciences to Advance Small Molecule Drugs that Upregulate apoE
9. Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs
10. Quantum Materials Tetrapod Quantum Dots Break Kashas Rule: Enhanced Performance Enables Commercialization of Novel Discovery
11. Novira Therapeutics Expands Management Team with Appointment of Klaus Klumpp, Ph.D., the Former Global Head of Roches Virology Discovery Initiatives, as Vice President Discovery Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... Pa. , June 19, 2017  Researchers from ... today that they will host a live, complimentary webinar ... from the benchtop to the real world" on Wednesday ... EDT. This webinar will feature interviews ... rare look into the manipulation techniques abusers use to ...
(Date:6/14/2017)...  ivWatch LLC, a medical device company focused on ... is pleased to announce it was the Bronze Winner ... and Equipment at the 2017 Medical Design Excellence Awards ... The award was presented by Medical Device and Diagnostics ... New York during MD&M East, ...
(Date:6/13/2017)... WARSAW, Ind. , June 13, 2017 Zimmer ... in musculoskeletal healthcare, today announced that the U.S. Food and ... Letter dated June 3, 2015 relating to its ... "The successful clearance of ... China manufacturing facility is a measure of the ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... June 20, 2017 , ... ... has published a new eBook titled “ 5 Questions to Ask Before Entering ... Analyst on the Genetic Test Evaluation (GTE) team, the book explores the various ...
(Date:6/20/2017)... ... June 20, 2017 , ... HOUSTON – Brazos ... and a host of new options for today’s modern senior. Brazos Towers at ... active, independent lifestyle they love while offering them the services to support that lifestyle ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a ... Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without ...
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... ... (IPI) Clinical Innovation Catalyst program focused on finding product improvements that ... tubes placed in their throats when they need help breathing or to provide ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... the security systems industry has been selected as the partner of choice by ... a passenger railroad service that provides medium- and long-distance intercity service in the ...
Breaking Medicine News(10 mins):